1.北京中医药大学东直门医院(北京 100700)
2.北京中医药大学中医学院(北京 100029)
姚欣凝,女,博士研究生,主要从事中医药防治消化系统疾病研究工作
丁霞,主任医师,教授,博士研究生导师; E-mail:dingx@bucm.edu.cn
扫 描 看 全 文
姚欣凝,李萍,丁霞.从整合医学的视角探讨慢性胃炎“炎⁃癌转化”的防治[J].上海中医药杂志,2023,57(6):6-11.
YAO Xinning,LI Ping,DING Xia.Prevention and treatment of inflammation⁃cancer transformation of chronic gastritis from the perspective of holistic integrative medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(6):6-11.
姚欣凝,李萍,丁霞.从整合医学的视角探讨慢性胃炎“炎⁃癌转化”的防治[J].上海中医药杂志,2023,57(6):6-11. DOI: 10.16305/j.1007-1334.2023.2303098.
YAO Xinning,LI Ping,DING Xia.Prevention and treatment of inflammation⁃cancer transformation of chronic gastritis from the perspective of holistic integrative medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(6):6-11. DOI: 10.16305/j.1007-1334.2023.2303098.
整合医学强调以人为本,结合社会、环境和心理的现实,将医学各领域的知识理论和实践经验进行有机整合,多学科交叉,使之成为更加有利于人体健康和疾病治疗的新医学体系,是未来医学发展的重要方向。慢性胃炎“炎-癌转化”是横跨消化和肿瘤两个专科的问题,其多病因、多机制、多途径、多阶段的特点为本病的科学防治带来了困难与挑战,从整合医学的视角出发,整合多学科的技术和信息,将有助于解决这一问题,为延缓、阻断慢性胃炎“炎-癌转化”以及降低胃癌发病率提供方向与策略。从整合医学的视角探讨慢性胃炎“炎-癌转化”的防治,具体包括以下几个方面:①医患协同,从多方面进行生活方式管理;②动态防治,“防、筛、诊、治、康”分阶段全过程管理;③从“胃内微环境”的整合视角认识、指导慢性胃炎“炎-癌转化”的防治;④多学科交叉,共筑整合防治新战略,包括中西医结合、基础研究与临床诊疗的相互促进以及引入现代科学技术等。
Holistic integrative medicine (HIM) is people-oriented, which facilitates the organic integration of knowledge, theories and practical experience from various fields of medicine based on social, environmental and psychological realities. HIM is developing into a new medical system that is more conducive to human health and disease treatment, and is an important direction for future medical development. The “inflammation-cancer transformation” of chronic gastritis is a problem involving two specialties: gastroenterology and oncology, whose multi-causes, multi-mechanisms, multi-pathways, and multi-stage characteristics bring difficulties and challenges to the scientific prevention and treatment. HIM can help to solve this problem, providing directions and strategies to delay and stop the “inflammation-cancer transformation” in chronic gastritis and reduce the incidence of gastric cancer by integrating multidisciplinary techniques and information.The prevention and treatment of “inflammation-cancer transformation” in chronic gastritis is explored from the perspective of HIM, including the following aspects: ①Collaboration between doctors and patients for lifestyle management from various aspects; ②Dynamic prevention and treatment through the whole process management of “prevention-screening-diagnosis-treatment-rehabilitation”; ③Guidance on the prevention and treatment of the “inflammation-cancer transformation” in chronic gastritis from the integrated perspective of the “gastric microenvironment”; ④The multidisciplinary intersection promotes the new development of integrated prevention and treatment, including mutual promotion of integrated Chinese and western medicine, basic research and clinical diagnosis and treatment, as well as the introduction of modern science and technology.
整合医学慢性胃炎胃癌炎-癌转化多学科交叉中医药疗法
holistic integrative medicine (HIM)chronic gastritisgastric cancerinflammation-cancer transformationmultidisciplinary intersectiontraditional Chinese medicine therapy
樊代明. 整合医学初探[J]. 医学争鸣,2012, 3(2): 3-12.
樊代明. HIM,医学发展新时代的必然方向[J]. 医学争鸣,2017, 8(1): 1-10.
樊代明. 整合医学——医学发展新时代[J]. 中华医学杂志,2016, 96(22): 1713-1718.
ZHENG R, ZHANG S, ZENG H, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
CORREA P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]. Cancer Res, 1992, 52(24): 6735-6740.
房静远,杜奕奇,刘文忠,等. 中国慢性胃炎共识意见(2017年,上海)[J]. 中华消化杂志,2017, 37(11): 721-738.
赫捷,陈万青,李兆申,等. 中国胃癌筛查与早诊早治指南(2022,北京)[J]. 中国肿瘤,2022, 31(7): 488-527.
刘文忠. “幽门螺杆菌胃炎京都全球共识”解读[J]. 胃肠病学,2015, 20(8): 449-456.
LI W Q, ZHANG J Y, MA J L, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial[J]. BMJ, 2019, 366: I5016.
FORD A C, YUAN Y, MOAYYEDI P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis[J]. Gut, 2020, 69(12): 2113-2121.
CHEN H N, WANG Z, LI X, et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis[J]. Gastric Cancer, 2016, 19(1): 166-175.
WANG F, XIA P, WU F, et al. Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells[J]. J Biol Chem, 2008, 283(39): 26714-26725.
应镇光,张焕芝,靳广毅,等. 胃癌发生及其耐药性形成中的相关信号通路[J]. 中国组织化学与细胞化学杂志,2016, 25(3): 291-294.
张慧,聂平平,焦石,等. 胃肠道肿瘤发生及免疫应答的细胞信号机制[J]. 生命的化学,2022, 42(5): 882-891.
ZAGARI R M, RABITTI S, GREENWOOD D C, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis[J]. Aliment Pharmacol Ther, 2017, 46(7): 657-667.
TU H, SUN L, DONG X, et al. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study[J]. Am J Gastroenterol, 2017, 112(5): 704-715.
王萍,李鹏,陈萦晅,等. 中国整合胃癌前病变临床管理指南[J]. 胃肠病学,2021, 26(2): 91-111.
国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟(GECA), 中华医学会消化病学分会幽门螺杆菌学组,等. 中国胃黏膜癌前状态及病变的处理策略专家共识(2020)[J]. 中华消化内镜杂志,2020, 37(11): 769-780.
王永炎. 整合医学理念的形成与提出[J]. 北京中医药大学学报,2016, 39(7): 533-535.
樊代明. 整合医学[M]. 北京:世界图书出版公司,2016.
胡振飞. 健身气功锻炼对大学生脾胃病症状的干预研究[D]. 曲阜:曲阜师范大学,2021.
DU S H, LI Y, SU Z Q, et al. Index-based dietary patterns in relation to gastric cancer risk: a systematic review and meta-analysis[J]. Br J Nutr, 2020, 123(9): 964-974.
中华人民共和国国家卫生健康委员会医政医管局. 胃癌诊疗指南(2022年版)[J]. 中华消化外科杂志,2022, 21(9): 1137-1164.
李凯. CACA胃癌整合诊治指南(精简版)[J]. 中国肿瘤临床,2022, 49(14): 703-710.
郭涛,钱家鸣. 幽门螺杆菌感染相关的低胃酸分泌与胃癌发生[J]. 中华临床医师杂志(电子版),2016, 10(5): 712-717.
曹婉琛. 基于壁细胞超微结构探究慢痞消防治胃癌前病变大鼠的作用机制[D]. 北京:北京中医药大学,2020.
樊代明. HIM,医学发展新时代的必由之路[J]. 医学争鸣,2017, 8(3): 1-19.
王键. 中医基础理论[M]. 北京:中国中医药出版社,2016.
陈可冀,宋军. 病证结合的临床研究是中西医结合研究的重要模式[J]. 世界科学技术,2006, 8(2): 1-5.
王振宇,姚海强,王琦. 辨体-辨病-辨证诊疗模式的临床运用[J]. 中医杂志,2016, 57(22): 1921-1924.
韩萍萍. 体质辨识与三辨诊疗模式在慢性胃炎中应用的临床观察[D]. 天津:天津中医药大学,2021.
吴皓萌,黄绍刚,王凤云,等. 基于胃微环境探讨中医药防治胃癌前病变的机制[J]. 中国实验方剂学杂志,2021, 27(16): 245-250.
向桢. 早期胃癌联合筛查及胃癌中高风险人群的中医体质管理研究[D]. 南宁:广西中医药大学,2021.
邢建菲,苏倩奕,吴海新,等. 中医外治法在慢性萎缩性胃炎中的应用研究进展[J]. 世界中医药,2023, 18(1): 137-140.
覃尚红,梁丽,周成华,等. 基于五行音乐疗法中医情志护理对老年慢性胃炎伴抑郁患者症状及生活质量的影响[J]. 现代中西医结合杂志,2022, 31(5): 697-700.
黄灵姗,林丽英,俞静. 八段锦在40例肝胃不和型慢性胃炎中运用[J]. 福建中医药,2017, 48(6): 71-72.
胡伏莲,张声生. 全国中西医整合治疗幽门螺杆菌相关“病-证”共识[J]. 胃肠病学和肝病学杂志,2018, 27(9): 1008-1016.
朱正纲,傅国辉,刘炳亚,等. 分子标志物在胃癌发病机制及转化医学研究中的应用[J].上海交通大学学报(医学版),2012, 32(9): 1185-1197.
ZHOU C B, PAN S Y, JIN P, et al. Fecal signatures of streptococcus anginosus and streptococcus constellatus for noninvasive screening and early warning of gastric cancer[J]. Gastroenterology, 2022, 162(7): 1933-1947.
LI Y, LI T, CHEN J, et al. Manpixiao Decoction halted the malignant transformation of precancerous lesions of gastric cancer: from network prediction to in-vivo verification[J]. Front Pharmacol, 2022, 13: 927731.
于春月,李依聪,苏泽琦,等. 慢痞消对慢性萎缩性胃炎大鼠血清炎症指标IL-1β、IL-6和TNF-α表达水平的影响[J]. 中华中医药杂志,2019, 34(5): 1979-1983.
李依聪. 基于胃内菌群及lncRNA-mRNA互作探究慢痞消防治慢性胃炎炎癌转化的机制[D]. 北京:北京中医药大学,2020.
胡伟玲. 胃癌前病变精准监测和癌变有效逆转诊疗系统数字化建设[D]. 杭州:浙江大学,2014.
刘健,闫秀娥,周丽雅,等. 全谱氨基酸代谢组学在胃癌诊断中的应用[J]. 胃肠病学和肝病学杂志,2019, 28(1): 10-14.
XU H, ZHANG Y, WANG P, et al. A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine[J]. Acta Pharm Sin B, 2021, 11(6): 1379-1399.
向阳,吕文亮. 基于整合药理学的黄连-厚朴药对防治慢性胃炎“炎-癌转化”作用机制探讨[J]. 湖北中医杂志,2021, 43(7): 52-56.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构